The market for extremity replacement implants is expected to reach nearly $2bn by 2024, a healthy rebound given the almost 11% dip in 2020 due to COVID-19. This marks a compound annual growth rate (CAGR) of 3.9%, according to a new Meddevicetracker forecast.
Geographically, in 2019, the US accounted for 58% of the extremities replacement implants market. The five major European markets (UK, Germany, Spain, Italy, and France) and Japan accounted for 12%...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?